Mostrando 2 resultados de: 2
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusAntiproliferative and proapoptotic effects of astemizole on cervical cancer cells
ArticleAbstract: Objective: Cervical cancer is a major cause of mortality among women in developing countries. Thus,Palabras claves:Astemizole, Cervical Cancer, Ether à-go-go, Imipramine, Potassium channelsAutores:de Guadalupe Chávez-López M., Gariglio P., Hernández-gallegos E., Javier Camacho, Vázquez-Sánchez A.Y.Fuentes:scopus